High-grade research TB-500 should exhibit a purity percentage of 98.0% or higher, verified via Reverse-Phase HPLC and mass spectrometry. PX1 Research supplies USA-synthesized, third-party COA-verified TB-500 with lot-specific RP-HPLC, identity confirmation, and endotoxin screening (<0.05 EU/mg). Orders ship same-day Monday through Friday from dispatch facilities in Arizona and California to ensure rapid delivery for critical in vitro and animal assays.
High-grade research TB-500 should exhibit a purity percentage of 98.0% or higher, verified via Reverse-Phase HPLC and mass spectrometry. PX1 Research supplies USA-synthesized, third-party COA-verified TB-500 with lot-specific RP-HPLC, identity confirmation, and endotoxin screening (<0.05 EU/mg). Orders ship same-day Monday through Friday from dispatch facilities in Arizona and California to ensure rapid delivery for critical in vitro and animal assays.
When evaluating synthetic TB-500 (Thymosin Beta-4 synthetic fragment) for laboratory use, the target purity percentage measured by Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) must be at least 98.0%, with premium analytical batches reaching 99.0% or greater. HPLC purity quantifies the absence of closely eluting peptide impurities, deletion sequences, and truncated side products.
Beyond HPLC purity percentage, complete quality control requires Liquid Chromatography-Mass Spectrometry (LC-MS) to confirm exact molecular mass (4,963.5 Da), net peptide content determination (typically 75%–85% active peptide by weight), trifluoroacetate (TFA) counter-ion monitoring, and Limulus Amebocyte Lysate (LAL) testing to confirm endotoxin levels below 0.05 EU/mg.
Researchers should never rely on generic or unverified supplier specification sheets. Every batch must be paired with a downloadable, lot-traceable Certificate of Analysis (COA) issued by an independent ISO/IEC 17025-accredited testing facility.
TB-500 is a synthetic peptide derived from the active region of Thymosin Beta-4, a naturally occurring 43-amino acid peptide present in high concentrations in blood platelets, wound fluid, and tissue structures. Classed broadly as a regeneration peptide, TB-500 is investigated in preclinical models for its role in promoting cell migration, blood-vessel formation (angiogenesis), and structural flexibility during soft-tissue and muscle-fiber recovery.
In vitro assays examining actin sequestration, focal adhesion assembly, and microvascular endothelial tube formation are exceptionally sensitive to structural contaminants. Sub-standard peptide batches containing synthesis fragments or residual heavy metals can induce cellular toxicity, non-specific binding, or variable receptor signaling, masking legitimate biological responses.
To achieve reproducible research outcomes, investigators must utilize high-purity compounds. Labs preparing to conduct cellular migration or tissue remodeling protocols can order 10 mg vials of TB-500 manufactured under strict solid-phase synthesis quality standards.
Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) is the analytical benchmark for determining the purity percentage of synthesized peptides. The process separates chemical species based on hydrophobic interactions between the peptide molecules and a non-polar stationary phase (typically a C18 silica column), driven by a gradient of polar mobile phases (such as water and acetonitrile containing 0.1% TFA).
As the sample elutes through the column, a UV spectrophotometer records absorbance—typically at a wavelength of 214 nm, which corresponds to the absorption peak of peptide bonds. The resulting chromatogram displays distinct peaks representing the main compound and any secondary impurities. The TB-500 purity percentage is calculated by integrating the area under the primary peak relative to the sum of all integrated peak areas.
A threshold of ≥98.0% RP-HPLC purity guarantees that secondary peak areas—representing minor deletion sequences, incomplete coupling fragments, or oxidation artifacts—comprise no more than 2.0% of the total sample absorbance. In sensitive cell culture applications, batches testing at ≥99.0% are preferred to eliminate potential cellular background noise.
A common point of confusion among laboratory buyers is the distinction between gross powder mass and net peptide content. When a vial is labeled as containing 10 mg of TB-500, the total lyophilized cake inside the vial weighs 10 mg gross. However, this total weight is not 100% active peptide sequence.
During Solid-Phase Peptide Synthesis (SPPS) and subsequent purification, peptides are cleaved using trifluoroacetic acid (TFA). As a result, basic amino acid residues (such as lysine and arginine) form TFA counter-ion salts. Additionally, lyophilized cakes absorb residual moisture from atmospheric humidity during packaging.
Net peptide content represents the actual mass proportion of the pure 43-amino acid sequence within the total cake, excluding TFA salt counter-ions and bound hydration water. Typically, net peptide content ranges between 75% and 85% of total gross weight. Researchers performing strict stoichiometric dosage calculations must account for net peptide content as reported on the batch COA rather than assuming 100% dry-mass peptide conversion.
While RP-HPLC measures sample purity by separating compounds based on elution time, it cannot confirm that the main peak is indeed TB-500. A compound with a completely different sequence could theoretically co-elute at the exact same retention time under specific gradient conditions.
To definitively establish molecular identity, laboratories perform Mass Spectrometry—most commonly Electrospray Ionization Liquid Chromatography-Mass Spectrometry (ESI-LC-MS) or Matrix-Assisted Laser Desorption/Ionization (MALDI-TOF). Mass spectrometry measures the exact mass-to-charge ratio (m/z) of the ionized peptide sequence.
The theoretical molecular weight of TB-500 (Thymosin Beta-4) is 4,963.5 Da. High-resolution mass spectra must yield parent ion signals matching this theoretical value within a tolerance of ±1.0 Da. Mass spectrometry also detects deletion sequence artifacts where individual amino acids were skipped during automated coupling cycles.
Bacterial endotoxins—lipopolysaccharides (LPS) derived from the outer cell membrane of Gram-negative bacteria—are potent pyrogens that can contaminate laboratory reagents. In cell culture models, endotoxins activate Toll-like receptor 4 (TLR4) pathways, causing inflammatory cytokine release, cell death, or unexpected gene expression shifts.
In peptide manufacturing, endotoxin contamination can arise from non-sterile process water, raw material impurities, or improper lyophilization environment control. High HPLC purity percentages do not automatically guarantee low endotoxin levels, as LPS molecules do not absorb UV light at 214 nm in the same manner as peptide bonds.
Endotoxin levels are measured using the Chromogenic Limulus Amebocyte Lysate (LAL) assay and reported in Endotoxin Units per milligram (EU/mg). For preclinical in vitro and animal models, research-grade TB-500 must maintain endotoxin levels strictly below 0.05 EU/mg, with analytical-grade batches demonstrating <0.01 EU/mg.
Reviewing a Certificate of Analysis prior to unboxing reagents ensures experimental control and safety. A valid, comprehensive COA for TB-500 must contain the following specific elements:
1. **Header & Lot Traceability**: Verify that the document lists a distinct lot/batch number that directly matches the physical vial label in your shipment, alongside manufacturing and re-test dates.
2. **RP-HPLC Chromatogram**: Inspect the visual chromatogram. Look for a clean baseline without drifting or severe noise. Below the chart, check the integration table: the primary TB-500 peak area percentage must meet or exceed 98.0%.
3. **Mass Spectrum Data**: Confirm the observed molecular weight peak matches 4,963.5 Da (±1 Da). Ensure no prominent secondary mass peaks exist that would signal deletion peptides.
4. **Net Peptide Content & Moisture**: Look for elemental nitrogen analysis or quantitative HPLC comparison indicating net peptide content (75%–85%) and Karl Fischer titration showing water content below 5.0%.
5. **Endotoxin Screening Results**: Confirm an explicit numerical LAL test result (e.g., '<0.02 EU/mg') rather than vague statements such as 'pass' or 'low'.
Investigators can explore full analytical documentation across our comprehensive research peptide catalog to review standard COA reporting structures.
To simplify vendor selection for procurement managers and laboratory directors, the following structured criteria outline the required quality standards for commercial TB-500:
- **Purity Threshold**: Minimum 98.0% by RP-HPLC at 214 nm peak detection.
- **Identity Verification**: ESI-MS or MALDI-TOF sequence confirmation matching 4,963.5 Da.
- **Counter-Ion Profile**: Controlled TFA levels with optional acetate conversion upon request.
- **Endotoxin Limit**: Less than 0.05 EU/mg confirmed via chromogenic LAL assay.
- **Physical Appearance**: Lyophilized, white to off-white compact cake; clear and colorless upon reconstitution in sterile bacteriostatic water.
- **Traceability**: Independent third-party testing with lot-specific downloadable reports.
- **Fulfillment & Storage**: Nitrogen-flushed vials dispatched via tracked domestic courier from temperature-monitored hubs.
The market for research reagents includes vendors operating without strict laboratory quality control. Common red flags when sourcing TB-500 include:
Missing or generic COAs: Avoid suppliers providing a single static PDF without lot-specific batch numbers or testing dates. A valid COA must reflect the precise lot received.
Cropped Chromatograms: Be suspicious of HPLC reports that crop out the baseline or omit the peak area integration table. Unintegrated secondary peaks often hide heavy impurity loads.
Absence of Mass Spectrometry: HPLC alone cannot prove molecular identity. A vendor offering HPLC purity percentages without mass spec spectra cannot confirm that the compound is true TB-500.
Unrealistic Purity Claims: Vendors claiming '100% purity' or 'zero TFA content' without specialized salt conversion are advertising scientifically inaccurate metrics. All standard SPPS peptides contain minor counter-ions and trace moisture.
Medical or Dosing Instructions: Suppliers presenting human administration guidelines, therapeutic claims, or personal injection advice violate research compliance standards. Vendor communications must focus strictly on laboratory research specs.
TB-500 is frequently evaluated alongside other synthetic compounds targeting tissue repair, cell migration, and cell signaling networks in preclinical models.
For example, researchers studying synergistic soft-tissue recovery models often co-examine BPC-157 5 mg vials, a pentadecapeptide investigated for its effects on tendon-to-bone healing, nitric oxide pathway regulation, and gastrointestinal mucosal repair. Additional information on this pathway is available in our BPC-157 research hub.
Similarly, GHK-Cu copper peptide is routinely studied for its role in extracellular matrix remodeling, collagen synthesis, and gene expression regulation in dermal fibroblast cultures. To review technical specifications across these target groups, consult our TB-500 research guide or access our broader research documentation library.
PX1 Research supplies USA-synthesized, high-purity TB-500 specifically formulated for in vitro research and animal model studies. Every lot undergoes rigorous third-party analytical verification, ensuring our TB-500 10 mg lyophilized vials consistently meet or exceed 98.0% RP-HPLC purity, precise mass identity, and ultra-low endotoxin limits.
What Ships with Your Order:
- Vacuum-sealed, nitrogen-flushed glass vials containing 10 mg lyophilized TB-500 cake.
- Lot-specific serial batch coding directly linked to downloadable online COA files.
- Same-day dispatch for orders placed before 2:00 PM local time (M–F) from distribution centers in Phoenix, AZ and San Diego, CA.
- Fast, tracked domestic shipping with secure protective packaging.
- Dedicated technical customer support for laboratory buyers and institutional procurement offices.
For bulk inquiries, custom synthesis schedules, or specialized institutional requirements, visit our wholesale peptide program or secure your analytical inventory directly online today.
What is the acceptable purity percentage for research-grade TB-500?
The minimal acceptable HPLC purity percentage for research-grade TB-500 is 98.0%, with premium analytical batches reaching 99.0% or higher. High purity ensures that cellular migration and angiogenesis assays remain free from interference by truncated peptide fragments or chemical impurities generated during solid-phase synthesis.
How do I verify the TB-500 purity percentage on a COA?
To verify TB-500 purity percentage, locate the Reverse-Phase HPLC chromatogram on the Certificate of Analysis. Examine the integrated area percent table below the chromatogram. The main peak corresponding to TB-500 should account for at least 98.0% of the total integrated peak area at a UV wavelength of 214 nm.
What is the difference between gross weight and net peptide content for TB-500?
Gross weight refers to the total lyophilized mass inside the vial, which includes the active TB-500 peptide, trifluoroacetate (TFA) counter-ions, and bound residual water. Net peptide content reflects the actual percentage of peptide mass relative to total powder weight, typically ranging between 75% and 85% in high-grade research preparations.
Why is mass spectrometry necessary alongside HPLC testing for TB-500?
While RP-HPLC measures sample purity by separating compounds based on hydrophobicity, it cannot confirm chemical identity. Mass spectrometry (LC-MS or MALDI-TOF) measures the exact mass-to-charge ratio of the molecule, verifying that the main HPLC peak corresponds precisely to the molecular weight of TB-500 (4,963.5 Da).
What are acceptable endotoxin levels in TB-500 research samples?
Acceptable endotoxin limits for in vitro and preclinical TB-500 research samples should be below 0.05 EU/mg (Endotoxin Units per milligram), with top-tier analytical lots measuring under 0.01 EU/mg. Low endotoxin counts prevent inflammatory signaling artifacts in sensitive tissue culture models.
Is TB-500 stable at room temperature during shipping?
Lyophilized TB-500 peptide powder is highly stable at ambient temperatures during standard transit times (2 to 5 days). Upon arrival at the laboratory, vials should be stored at -20°C or -80°C for long-term stability, while reconstituted solutions require refrigerated storage at 2°C to 8°C.
Does PX1 Research provide lot-specific COAs for TB-500?
Yes, PX1 Research provides downloadable, lot-specific Certificates of Analysis for every batch of TB-500. Each COA includes complete RP-HPLC purity chromatograms, mass spectrometry identity confirmation, TFA counter-ion quantification, and chromogenic LAL endotoxin testing results.
How fast does PX1 Research ship TB-500 orders?
Orders placed with PX1 Research before 2:00 PM local time Monday through Friday ship the same day. Shipments dispatch from dual fulfillment facilities in Arizona and California, offering fully tracked domestic transit across the United States.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.